4//SEC Filing
Chu Yu-Waye 4
Accession 0001610717-23-000208
CIK 0001501989other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 5:18 PM ET
Size
5.4 KB
Accession
0001610717-23-000208
Insider Transaction Report
Form 4
Chu Yu-Waye
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-19+375,000→ 375,000 totalExercise: $1.82Exp: 2033-07-18→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the one year anniversary measured from July 19, 2023 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001854586
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 5:18 PM ET
- Size
- 5.4 KB